-
ITOS Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
iTeos Therapeutics (ITOS)
Company Profile
Quarter (USD) | Sep 24 | Jun 24 | Mar 24 | Dec 23 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 124.05 mm | 124.05 mm | 124.05 mm | 124.05 mm | 124.05 mm | 124.05 mm |
Cash burn (monthly) | 42.45 mm | 6.70 mm | 16.27 mm | 12.53 mm | 12.45 mm | 9.79 mm |
Cash used (since last report) | 215.70 mm | 34.02 mm | 82.65 mm | 63.66 mm | 63.26 mm | 49.73 mm |
Cash remaining | -91.64 mm | 90.03 mm | 41.40 mm | 60.39 mm | 60.79 mm | 74.32 mm |
Runway (months of cash) | -2.2 | 13.4 | 2.5 | 4.8 | 4.9 | 7.6 |
13F holders | Current |
---|---|
Total holders | 139 |
Opened positions | 27 |
Closed positions | 39 |
Increased positions | 50 |
Reduced positions | 44 |
13F shares | Current |
---|---|
Total value | 255.86 bn |
Total shares | 41.25 mm |
Total puts | 2.45 mm |
Total calls | 454.00 k |
Total put/call ratio | 5.4 |
Largest owners | Shares | Value |
---|---|---|
BlackRock | 3.80 mm | $29.20 bn |
Boxer Capital | 2.95 mm | $27.76 mm |
MPM Asset Management | 2.74 mm | $21.03 bn |
Biotechnology Value Fund L P | 2.33 mm | $18.90 mm |
BVF | 2.33 mm | $17.86 bn |
Ra Capital Management | 2.09 mm | $16.07 bn |
JPM JPMorgan Chase & Co. | 2.07 mm | $15.89 bn |
MPM BioVentures 2014 | 1.84 mm | $59.33 mm |
MPM Oncology Impact Management | 1.75 mm | $13.41 bn |
Vanguard | 1.63 mm | $12.55 bn |
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
6 Dec 24 | David Feltquate | Common Stock | Grant | Acquire A | No | No | 0 | 47,000 | 0.00 | 47,000 |
19 Nov 24 | Matthew Gall | Common Stock | Buy | Acquire P | No | No | 7.727 | 5,000 | 38.64 k | 65,429 |
8 Aug 24 | Michel Detheux | Stock Option Common Stock | Gift | Acquire G | Yes | No | 11.58 | 442,800 | 5.13 mm | 442,800 |
8 Aug 24 | Michel Detheux | Stock Option Common Stock | Gift | Dispose G | No | No | 11.58 | 442,800 | 5.13 mm | 147,600 |
1 Aug 24 | David Feltquate | Stock Option Common Stock | Grant | Acquire A | No | No | 17.46 | 350,000 | 6.11 mm | 350,000 |